Intrahepatic cholestasis in sickle cell disease: a case report
- PMID: 21490769
- PMCID: PMC3065851
- DOI: 10.1155/2011/975731
Intrahepatic cholestasis in sickle cell disease: a case report
Abstract
Intrahepatic cholestasis (SCIC) is an uncommon but potentially fatal complication of sickle cell disease (SCD), with a high death rate, observed mainly in patients with homozygous sickle cell anemia. Herein, we describe a case of severe SCIC treated successfully with aggressive manual exchange transfusion (ET). The patient was admitted with enlarged liver and signs of hepatic failure, such as hyperbilirubinemia and coagulopathy. There was no evidence of viral hepatitis or biliary obstruction. We performed several sessions of ET in order to reduce the percentage of HbS to levels inferior to 30%, which was successfully accomplished. The patient had a complete recovery of hepatic function. This case has shown that ET is an effective treatment of SCIC and should be introduced early on the onset of this severe complication.
Figures
References
-
- Ebert EC, Nagar M, Hagspiel KD. Gastrointestinal and hepatic complications of sickle cell disease. Clinical Gastroenterology and Hepatology. 2010;8(6):483–489. - PubMed
-
- Banerjee S, Owen C, Chopra S. Sickle cell hepatopathy. Hepatology. 2001;33(5):1021–1028. - PubMed
-
- Berry PA, Cross TJS, Thein SL, et al. Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment. Clinical Gastroenterology and Hepatology. 2007;5(12):1469–1476. - PubMed
-
- Owen DM, Aldridge JE, Thompson RB. An unusual hepatic sequel of sickle cell anemia: a report of five cases. The American Journal of the Medical Sciences. 1965;249:175–185. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
